Search…

Lates News

13/08/2025

According to the AI Express of Every Economy, Huaxin Securities issued a research report on August 13, giving Ganli Pharmaceutical (603087.SH) a buy rating. The main reasons for the rating include: 1) impressive performance in the first half of 2025, with both volume and price rising domestically, and high growth in overseas markets; 2) orderly advancement of innovative product pipeline, with core products entering phase III clinical trials. (Daily Economic News)

Latest

1 m ago

Lebanese President Aoun: Apart from the security forces, no one in Lebanon is allowed to carry weapons. We reject any interference in our internal affairs.

1 m ago

Polaris (300905.SZ) releases its semi-annual performance report, with a net profit attributable to shareholders of 63.81 million yuan, representing a year-on-year increase of 15.19%.

2 m ago

Yankuang Energy (01171.HK) issues profit warning, expecting a net profit attributable to the parent of approximately 4.65 billion yuan in the first half of the year, a year-on-year decrease of around 38%.

3 m ago

Crowd Wisdom Consulting: The global shipment volume of smartphone panels in the first half of the year is approximately 1.09 billion pieces, with a steady increase of 14.2% for a-Si LCD panels due to cost advantages.

3 m ago

Hunan initiates level four emergency response for flood defense.

See all latest